Free Trial

Innovator IBD Breakout Opportunities ETF (BOUT) Institutional Ownership

$32.55 -2.78 (-7.87%)
Closing price 04:10 PM Eastern
Extended Trading
$32.71 +0.16 (+0.49%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$1.38M
Number of
Institutional Sellers
(last 12 months)
0
Get BOUT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Innovator IBD Breakout Opportunities ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BOUT Institutional Buying and Selling by Quarter

Remove Ads

Innovator IBD Breakout Opportunities ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/4/2025Comprehensive Money Management Services LLC31,423$1.23M1.0%N/A8.978%
2/17/2025Citadel Advisors LLC35,978$1.41M0.0%+10.1%8.995%
2/12/2025Murphy & Mullick Capital Management Corp653$26K0.0%N/A0.163%
11/10/2022Sigma Planning Corp12,594$353K0.0%+7.5%2.799%
8/11/2022Sigma Planning Corp11,710$353K0.0%N/A2.342%
8/3/2022Envestnet Asset Management Inc.33,376$1.01M0.0%N/A6.675%
7/29/2022Patriot Financial Group Insurance Agency LLC2,150$65K0.0%-23.2%0.430%
5/9/2022Csenge Advisory Group6,585$250K0.0%N/A1.317%
4/15/2022Wealthcare Advisory Partners LLC9,792$371K0.0%-6.6%2.176%
2/3/2022Cambridge Investment Research Advisors Inc.5,296$205K0.0%-37.3%1.177%
2/3/2022Advisor Group Holdings Inc.5,907$229K0.0%+146.5%1.313%
11/5/2021Advisor Group Holdings Inc.2,396$82K0.0%+16.3%0.599%
8/24/2021Flow Traders U.S. LLC21,259$707K0.0%+64.8%4.252%
8/11/2021Susquehanna International Group LLP37,620$1.25M0.0%+189.0%6.270%
8/2/2021Advisor Group Holdings Inc.2,060$69K0.0%-46.7%0.375%
5/18/2021Flow Traders U.S. LLC12,898$427K0.0%N/A1.984%
5/17/2021Eudaimonia Partners LLC962$32K0.0%-30.7%0.148%
5/12/2021UBS Group AG1,980$66K0.0%+2,855.2%0.305%
5/7/2021Cambridge Investment Research Advisors Inc.8,396$278K0.0%N/A1.292%
5/4/2021Envestnet Asset Management Inc.12,744$422K0.0%N/A1.961%
4/23/2021F3Logic LLC6,089$202K0.0%N/A0.937%
4/5/2021Fulcrum Equity Management98,267$3.25M1.3%N/A15.118%
3/26/2021Susquehanna International Group LLP10,134$320K0.0%N/A1.559%
(Data available from 1/1/2016 forward)

Remove Ads

BOUT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BOUT shares?

During the previous two years, the following institutional investors and hedge funds held shares of Innovator IBD Breakout Opportunities ETF shares: Citadel Advisors LLC ($1.41M), and Comprehensive Money Management Services LLC ($1.23M), Murphy & Mullick Capital Management Corp ($26K).Learn more on BOUT's institutional investors.

Which institutional investors have been buying Innovator IBD Breakout Opportunities ETF stock?

The following institutional investors have purchased Innovator IBD Breakout Opportunities ETF stock in the last 24 months: Comprehensive Money Management Services LLC ($31.42K), Citadel Advisors LLC ($3.31K), and Murphy & Mullick Capital Management Corp ($653.00).

How much institutional buying is happening at Innovator IBD Breakout Opportunities ETF?

Institutional investors have bought a total of 35,390 shares in the last 24 months. This purchase volume represents approximately $1.38M in transactions.



This page (NYSEARCA:BOUT) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners